Chromatin Changes Accompany the Developmental Activation of Insulin-like Growth Factor I Gene Transcription
Overview
Authors
Affiliations
Insulin-like growth factor I (IGF-I) is a potent regulator of postnatal growth in mammals, yet little is known about the developmental control of IGF-I synthesis. We have investigated the regulation of IGF-I expression in the rat in order to gain insight into the mechanisms of growth factor induction during early postnatal life. Steady-state levels of liver IGF-I mRNA increased by more than 15-fold during the period from fetal day 18 to postnatal day 7 and reached 50% of adult values by day 14. Transcription run-on experiments using isolated hepatic nuclei and direct analysis of nuclear RNA each demonstrated a comparable rise in nascent IGF-I mRNA over the same time period. Over 90% of transcripts were directed by promoter 1, the more 5' of the two IGF-I gene promoters. By contrast IGF-II gene transcription rates and mRNA levels fell during the first 3 weeks after birth, and albumin expression rose slightly. Analysis of chromatin structure around the IGF-I gene revealed 15 DNase I-hypersensitive sites in adult rat liver in the 120 kilobases (kb) comprising the 6 exon gene and its flanking regions (8 sites within 10 kb at the 5'-end including exons 1-3, 5 sites in the 50-kb third intron, and 2 sites in the 15-kb fifth intron). During development there was a progressive appearance of DNase I-hypersensitive sites that coincided with activation of IGF-I gene expression. One site that became fully hypersensitive by postnatal day 7 was mapped by in vivo DNAse I footprinting to the proximal 200 nucleotides of promoter 1. Since serum IGF-I values rose from 10 to 120 micrograms/liter during the initial postnatal week, these results indicate that transcriptional mechanisms are principally responsible for the stimulation of IGF-I synthesis that occurs shortly after birth. Because discrete changes in chromatin organization coincided with induction of IGF-I gene transcription, it is likely that a series of developmentally modulated transcription factors are involved the activation process.
Meyer K, Verkaik-Schakel R, Timens W, Kobzik L, Plosch T, Hylkema M Epigenetics. 2017; 12(12):1076-1091.
PMID: 29160127 PMC: 5810788. DOI: 10.1080/15592294.2017.1403691.
Alvarez-Nava F, Lanes R Int J Mol Sci. 2017; 18(10).
PMID: 28981462 PMC: 5666699. DOI: 10.3390/ijms18101624.
Fung C, Yang Y, Fu Q, Brown A, Yu B, Callaway C Pediatr Res. 2015; 78(1):14-23.
PMID: 25826117 DOI: 10.1038/pr.2015.70.
Hepatic-specific accessibility of Igf1 gene enhancers is independent of growth hormone signaling.
Santhanam M, Chia D Mol Endocrinol. 2013; 27(12):2080-92.
PMID: 24109593 PMC: 3857198. DOI: 10.1210/me.2013-1181.
Chia D, Young J, Mertens A, Rotwein P Mol Endocrinol. 2010; 24(4):779-89.
PMID: 20160126 PMC: 2852351. DOI: 10.1210/me.2009-0430.